BioCryst Pharmaceuticals Inc. | Balance Sheet
Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Cash & Short Term Investments
38,206.00
72,922.00
53,175.00
56,196.00
117,683.00
106,011
Total Accounts Receivable
2,115.00
9,490.00
6,243.00
8,768.00
6,117.00
4,293
Inventories
-
683.00
1,612.00
500.00
-
1,649
Other Current Assets
1,725.00
6,172.00
2,674.00
1,438.00
1,381.00
2,390
Total Current Assets
42,046.00
89,267.00
63,704.00
66,902.00
125,181.00
114,343
Net Property, Plant & Equipment
306.00
207.00
5,149.00
9,922.00
9,546.00
9,135
Total Investments and Advances
2,582.00
41,116.00
47,683.00
8,926.00
41,295.00
22,376
Other Assets
3,932.00
6,284.00
5,823.00
4,097.00
2,237.00
987
Total Assets
48,866.00
136,874.00
122,359.00
89,847.00
178,259.00
146,841
ST Debt & Current Portion LT Debt
-
30,000.00
27,804.00
28,243.00
35,221.00
Accounts Payable
4,174.00
2,849.00
9,307.00
4,269.00
6,337.00
Other Current Liabilities
11,082.00
24,838.00
25,146.00
21,848.00
33,278.00
Total Current Liabilities
15,256.00
57,687.00
62,257.00
54,360.00
74,836.00
Long-Term Debt
30,000.00
-
2,375.00
25,481.00
19,501.00
Other Liabilities
4,736.00
3,552.00
10,003.00
8,428.00
155.00
Total Liabilities
49,992.00
61,239.00
74,635.00
88,269.00
94,492.00
Common Equity (Total)
1,126.00
75,635.00
47,724.00
1,578.00
83,767.00
Total Shareholders' Equity
1,126.00
75,635.00
47,724.00
1,578.00
83,767.00
Total Equity
1,126.00
75,635.00
47,724.00
1,578.00
83,767.00
Liabilities & Shareholders' Equity
48,866.00
136,874.00
122,359.00
89,847.00
178,259.00
About BioCryst Pharmaceuticals
View Profile
